IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Wildcat Capital Management, LLC

Q4 2024 Holdings

Filed 2025-01-29 | 8 holdings | $252.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Frontier Group Hldgs Inc(ULCC)COM35909R108$199.5M28,061,35179.0%
RLX Technology Inc(RLX)SPONSORED ADS74969N103$39.0M18,046,19515.4%
Allogene Therapeutics Inc(ALLO)COM019770106$6.2M2,920,7872.5%
Urogen Pharma LTD(URGN)COMM96088105$5.3M495,6062.1%
Kronos BIO Inc(KRON1USD)COM50107A104$1.2M1,297,9590.5%
Gitlab Inc(GTLB)CLASS A COM37637K108$642.3K11,3990.3%
Procore Technologies Inc(PCOR)COM74275K108$606.6K8,0950.2%
Silexion Therapeutics CorpSHS NEWG1281K122$228.0K113,4280.1%